Alex Perkins, Ph.D., Eck Family Assistant Professor in the Departments of Biological Sciences and Applied and Computational Mathematics and Statistics, and a member of the Eck Institute for Global Health, recently published a study looking at behavior of patients with one of the most common symptoms of disease: fever.  Surprisingly,...

Women in Science Regional Conference Sept. 30 – Oct. 1, 2016 The Association for Women in Science (AWIS) at Notre Dame is hosting the first ever Women in Science Regional Conference on Sep. 30th – Oct 1st. Graduate students will have the opportunity to network with high profile professionals from across the US, attend career development workshops and participate...

When battling cancer, everything is on the table. Radiation therapy. Surgery. Chemo. Advances in nanotechnology have enabled researchers, like Associate Professor Z. Basar Bilgicer, Research Assistant Professor Tanyel Kiziltepe, and their team in the Department of Chemical and Biomolecular Engineering at the University of Notre Dame, to encapsulate cancer-fighting/cancer-killing drugs...

Sharon Stack and Matt Ravosa joined the University of Notre Dame in 2011, coming from positions at the University of Missouri School of Medicine in Columbia, Missouri. Stack is the Ann F. Dunne and Elizabeth Riley Director of the Harper Cancer Research Institute (HCRI) and the Kleiderer-Pezold Professor of Chemistry...

Two Notre Dame graduate students, Nameera Baig and Nur Mustafaoglu, have been awarded the 2016 Berry Family Foundation Graduate Fellowships in Advanced Diagnostics & Therapeutics for their innovative research in tracking and treating disease.   …

Notre Dame’s Harper Cancer Research Institute is trying a different strategy in the fight against the disease: bringing scientists from diverse fields onto a single team. Introducing herself around campus in 2011, biochemist Sharon Stack sought faculty far outside her academic background. She wanted to get a feel for the...

As Richard Taylor completes a three-year term as associate vice president for research in June of this year, he will continue his research on drug discovery for rare genetic diseases, like NGLY1 deficiency, when he and other members of the Warren Family Research Center for Drug Discovery and Development move into the...

Michael Hildreth is appointed the next Associate Dean for Research and Graduate Studies effective July 1, 2016. He replaces Brian Baker, who steps down as associate dean after three years of leadership. Says Hildreth of his new role, “I’m excited and humbled by this opportunity to increase the breadth and...

VeriPAD, a startup created by a multidisciplinary team of City College of New York (CUNY) students and recent graduates in collaboration with University of Notre Dame faculty, was awarded the $25,000 Zahn Innovation Center social impact new venture competition grand prize.

In partnership with the Notre Dame Initiative for Global Development (NDIGD), Professor of Chemistry Marya Lieberman and her research team have received support from VWR , a leading global independent provider of product and service solutions to laboratory and production customers.

At the University of Notre Dame, the Molecular Structure Facility (MSF) analyzes organic or inorganic substances at an atomic level, which allows researchers to learn about the three-dimensional structure and connectivity of the compound they have created. Knowing the molecular make-up of substances oftentimes provides faculty, postdoctoral fellows, and graduate...

The University of Notre Dame’s Harper Cancer Research Institute will hold an open house from 4 to 6:30 p.m. June 28 (Tuesday) in Harper Hall. The event is free and open to the public, and refreshments will be provided.

The Graduate School is pleased to announce its second cohort of the Ethical Leaders in STEM program, a yearlong leadership development opportunity for third- and fourth-year PhD graduate students.

In late 2015, former President Jimmy Carter announced that he was free of the metastatic melanoma that had spread to his liver and brain. In addition to surgery and radiation, Carter was treated with an immunotherapy drug, a new approach in cancer treatment that has a promising outlook.

University of Notre Dame medical entomologist Nicole L. Achee is a member of a committee convened to summarize the scientific discoveries related to gene drives and considerations for their responsible use. The National Institutes of Health (NIH) and the Foundation for the National Institutes of Health asked the National Academies...

A collaboration among faculty in the Eck Institute for Global Health and the Warren Family Research Center for Drug Discovery and Development is investigating new ways to kill the mosquitoes that carry the Zika virus, dengue fever, and other dangerous diseases.

The University of Notre Dame will attend the 2016 BIO International Convention, which is hosted by the Biotechnology Innovation Organization (BIO) from June 6 - 9, 2016 in San Francisco. Represented Notre Dame Research groups at the event include the Harper Cancer Research Institute (HCRI), the Center for Nano Science and Technology...

Drugs to treat cancer and Alzheimer’s disease usually target the active sites of specific protein molecules sustaining the disease. Traditional drug design views proteins as rigid 3-D objects with active sites consisting of surface-accessible “pockets” with a specific, well-defined structure. Traditional drug design involves finding small molecules with shapes that...

Mr. Mike Harper, benefactor of the Harper Cancer Research Institute (HCRI), died this weekend in Omaha NE at the age of 88. 

Professors of chemistry and biochemistry, Paul Helquist and Olaf Wiest, together with Frederick Maxfield of Cornell University have received a U.S. patent for potential treatments for Niemann-Pick Type C (NPC) disease. Patent No. 9,333,222, “Histone deacetylase inhibitors as therapeutic agents for Niemann-Pick Type C Disease,” covers the full class of...